Details for 2014775675
Up to date per 03.04.2026
Actions
Details for 2014775675
Granted/Registered
European Patent
03.02.2016 A
15.04.2020 B1
24.03.2013
US
201361804690 P
24.12.2013
US
201314140083
A61K 31/19 20060101AFI20161013BHEP
Owner
Amylyx Pharmaceuticals Inc.43 Thorndike St Cambridge, MA 02141US
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
COHEN, Joshua B.118 Huntington Ave Apt. 306 Boston, Massachusetts 02116-5760US
KLEE, Justin169 Monsignor O'Brien Highway No.403 Cambridge, Massachusetts 02141US
Information about Fees